Year
2020
Status
Active
Team
Field
Autoimmune Diseases
Location
Toronto (CAN)
Fund
BGV IV
Fibrocor
Fibrocor is developing therapeutics based on a discovery platform for novel fibrosis targets.
2020
Active
Autoimmune Diseases
Toronto (CAN)
BGV IV
Fibrocor is developing therapeutics based on a discovery platform for novel fibrosis targets.